Larimar Therapeutics, Inc. · NASDAQ:LRMR

Shankar Gopi bought 5,000 Larimar Therapeutics, Inc. shares (Form 4)

Traded Nov 11, 2026 · Filed Nov 12, 2026

On Nov 11, 2026, Shankar Gopi (Chief Development Officer) bought 5,000 Larimar Therapeutics, Inc. shares at US$2.71 for US$13,549, leaving 81,443 shares. Filed Nov 12, 2026 (Form 4).

Bought
5,000 shares
Price
US$2.71
Value
US$13,549
Holding after
81,443 shares
Trading plan
No
Role
Chief Development Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 11, 2026Common StockBuy5,000US$2.7181,443Direct

Source

Download original · View original at SEC

Related